Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
Extraordinary Response to Mitotane Monotherapy in Advanced Aggressive Adrenocortical Carcinoma
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- Adrenocortical Carcinoma
- Oncological Management of Adrenocortical Carcinoma: An Update and Critical Review
- Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies
- Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
- Novel Targeted Therapies in Adrenocortical Carcinoma